Co-induction Technique for Balanced Anesthesia
Principles of Co-induction
- A co-induction technique using small doses of ketamine, midazolam, or fentanyl followed by reduced doses of propofol or sevoflurane provides the optimal balance for anesthesia, minimizing the negative effects of each agent while maximizing therapeutic benefits 1
- The balanced anesthesia approach is a well-established pharmacologic concept that maximizes therapeutic actions while minimizing dose-related adverse reactions 1
- By combining small doses of several drugs with desirable pharmacologic actions, more precise dose titration becomes possible, reducing the risk of adverse effects 1
Recommended Drug Combinations
- Propofol combined with small doses of an opioid analgesic and a benzodiazepine allows analgesia and amnesia to be achieved with subhypnotic doses of propofol, eliminating the need for deep sedation 1
- When propofol is used alone for sedation, larger doses are required, increasing the risk of dose-related side effects such as hypotension, hypoventilation, or bradycardia 1
Dosing Considerations
- For propofol, when used in combination therapy, average cumulative doses are reduced to 65-100 mg during colonoscopy and 35-70 mg during EGD, compared to much higher doses when used alone 1
Benefits of Co-induction
- More precise dose titration is possible with smaller bolus doses (e.g., 5-15 mg of propofol) 1
- Potential for pharmacologic reversibility is retained using naloxone or flumazenil when opioids or benzodiazepines are part of the regimen 1
- Reduced risk of respiratory depression and hypotension compared to single-agent high-dose techniques 1
Monitoring and Safety Considerations
- Careful monitoring of vital signs is essential during co-induction, particularly blood pressure and respiratory parameters 2
- Capnography has 100% sensitivity and specificity in identifying correct tracheal tube positioning in ventilated patients 2
- Target a moderate rather than deep sedation level when possible to minimize complications 1
- Have reversal agents readily available (naloxone for opioids, flumazenil for benzodiazepines) 1
Special Considerations
- In elderly patients or those with ASA physical status 3 or above, dose reductions of 20% or more may be necessary 3
- Patients with hepatic or renal impairment require dose adjustments, particularly for benzodiazepines 3